Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease - Alpha-1 Biomarker Research Consortium (A1BC)

NCT05297812 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT05297812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05297812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease - Alpha-1 Biomarker Research Consortium (A1BC)
Lead sponsor
Columbia University
Phase
Observational
Overall status
Active, not recruiting
Start date
March 23, 2022
Completion date
January 31, 2027
Enrollment
286 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

alpha 1-antitrypsin deficiency, genetic disease